WHO puts early diagnosis at top of global cancer fight
This article was originally published in Clinica
Executive Summary
Early detection is the key to preventing one third and treating a further third of the 10 million cases of cancer diagnosed globally every year. This is the conclusion of guidance published by the World Health Organization (WHO) on best policy and management of national cancer control programmes. "In far too many cases, primary prevention, early detection and palliative care are neglected in favour of treatment-oriented approaches, regardless of whether they are clinically and cost effective," said the WHO in its global assessment of national cancer policy.
You may also be interested in...
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.
UK MHRA Updates Assistive Tech And Borderline Regulations
Device classification themes were uppermost in April for the UK regulator, which issued key guidance in two areas prone to complexities. It also contributed to the MedTech Directorate’s one-year progress report.